AI assistant
CONMED Corp — Director's Dealing 2025
May 15, 2025
31971_dirs_2025-05-15_4f4254b7-7ce6-4315-b5da-1b743dd007f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-03-03
Reporting Person: Epinette Stephan (VP GM International)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | RSUs (Restricted Stock Units) | $0 | A | 17144 | Acquired | 2035-03-03 | Common Stock (17144) | Direct |
Footnotes
F1: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in a four year period with zero (0) shares vesting in 2026; 8,572 shares vesting on 3/3/27; 6,429 shares vesting on 3/3/28 and 2,143 vesting on 3/3/29.